|
시장보고서
상품코드
1831711
분자진단 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서 - 제품별, 검사 장소별, 기술별, 용도별, 지역별, 시장 예측(2025-2034년)Molecular Diagnostics Market Size, Share, Trend, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최근 조사에 따르면 분자진단 시장 규모는 2034년까지 380억 1,000만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
분자진단 시장은 분자 생물학적 기술을 이용하여 환자 샘플에서 유전 물질, 단백질 및 기타 특정 바이오마커를 검출하고 질병의 정확한 진단, 예후 예측 및 모니터링을 가능하게 하는 데 중점을 둡니다. 이 시장은 맞춤형 의료를 지원하는 정확하고 신속하며 침습성이 낮은 진단법에 대한 수요가 증가함에 따라 크게 성장하고 있습니다. 감염증, 암, 유전성 질환에 대한 유행의 고조가 임상 현장에서 분자진단의 채용을 가속시키고 있습니다. 디지털 PCR, 차세대 시퀀싱, 마이크로어레이와 같은 기술의 지속적인 발전으로 검사 감도, 특이성, 소요 시간이 향상되고 임상적인 의사결정이 강화되었습니다.
질병의 조기 발견에 대한 헬스케어 제공업체와 환자의 의식 증가는 예방 의료에서 광범위한 사용을 촉진합니다. 검사 플랫폼에서 AI와 자동화를 통합하면 워크플로우가 간소화되고 오류가 줄어들며 실험실 효율성이 향상됩니다. POC(Point of Care) 분자 검사의 확대에 의해 특히 긴급 의료에 있어서, 진단이 보다 친숙하고 시기 적절하게 되고 있습니다. 진단제 기업의 연구개발 투자 증가는 혁신적인 분석과 광범위한 검사 메뉴를 갖춘 플랫폼으로 이어지고 있습니다. 업계 동향으로는 분산형 검사 모델로의 이동, 표적 치료제의 동반자 진단의 성장, 진단 개발 및 제약 기업의 협력 관계 증가 등이 있습니다. 새로운 병원체에 대응하기 위한 검사 포트폴리오의 확대, 디지털 헬스와의 통합에 의한 원격 진단의 활용, 1회의 검사로 복수의 병태를 검출하는 멀티플렉스 검사의 진전 등에 비즈니스 기회가 있습니다. 정밀의료가 헬스케어를 계속 형성하고 빠르고 정확하며 확장 가능한 진단 솔루션이 요구되는 가운데, 이 시장은 지속적인 성장을 이루는 위치에 있습니다.
분자진단 시장 보고서 하이라이트
제품별로, 루틴 분자진단 워크플로우에서 소모품에 대한 지속적인 수요로 인해 시약 시스템 부문은 판매 점유율의 약 66%를 차지했고, 시장을 독점했습니다.
검사 장소별로는 중앙 검사실 부문이 2024년 매출 점유율의 80%를 차지했는데, 이는 중앙 검사실이 고급 장비와 전문 지식으로 대량의 검사를 처리할 수 있기 때문입니다.
북미의 분자진단 시장은 첨단 분자검사 기술의 강력한 도입과 확립된 헬스케어 인프라에 힘입어 최대 매출 점유율 41%를 차지했습니다.
아시아태평양 시장은 헬스케어 투자 증가, 첨단 진단 플랫폼의 급속한 도입, 만성 질환 및 감염의 부담 증가로 2025-2034년 큰 성장이 예상되고 있습니다.
세계 주요 기업으로는 Abbott, Agilent Technologies, Inc., BD, BIOMERIEUX, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche, Ltd., Grifols, Hologic Inc.(Gen Probe), Illumina, Inc., QIAGEN, Siemens Healthineers AG, Sysmex Corporation 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 분자진단 시장 인사이트
- 시장 현황
- 분자진단 시장 역학
- 성장 촉진요인 및 기회
- 감염증의 만연
- 지원적인 규제 및 자금 제공의 대처
- 성장 억제요인 및 과제
- 기기나 시약의 고비용에 의한 도입 제한
- 성장 촉진요인 및 기회
- PESTEL 분석
- 분자진단 시장력의 평가 동향
- 밸류체인 분석
제5장 분자진단 시장 : 제품별
- 주요 조사 결과
- 서문
- 기기
- 시약
- 기타
제6장 분자진단 시장 : 검사 장소별
- 주요 조사 결과
- 서문
- 포인트 오브 케어
- 셀프 테스트 또는 OTC
- 중앙연구소
제7장 분자진단 시장 : 기술별
- 주요 조사 결과
- 서문
- 중합효소 연쇄반응(PCR)
- 등온 핵산 증폭 기술(INAAT)
- 칩과 마이크로어레이
- 질량 분석
- 전사 중재 증폭(TMA)
- 기타
제8장 분자진단 시장 : 용도별
- 주요 조사 결과
- 서문
- 종양학
- 약리 유전체학
- 감염증
- 유전자 검사
- 신경질환
- 심혈관 질환
- 미생물학
- 기타
제9장 분자진단 시장 : 지역별
- 주요 조사 결과
- 서문
- 분자진단 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 검사 장소별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 검사 장소별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 검사 장소별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 검사 장소별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 검사 장소별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제11장 기업 프로파일
- Abbott
- Agilent Technologies, Inc.
- BD
- BIOMERIEUX
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche, Ltd
- Grifols
- Hologic Inc.(Gen Probe)
- Illumina, Inc.
- QIAGEN
- Siemens Healthineers AG
- Sysmex Corporation
The molecular diagnostics market size is expected to reach USD 38.01 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology, By Application, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The molecular diagnostics market focuses on the use of molecular biology techniques to detect genetic material, proteins, or other specific biomarkers in a patient's sample, enabling precise diagnosis, prognosis, and monitoring of diseases. This market has grown significantly due to the increasing demand for accurate, rapid, and minimally invasive diagnostic methods that support personalized medicine. The rising prevalence of infectious diseases, cancer, and genetic disorders has accelerated the adoption of molecular diagnostics in clinical settings. Continuous advancements in technologies such as digital PCR, next-generation sequencing, and microarrays are improving test sensitivity, specificity, and turnaround times, enhancing clinical decision-making.
Growing awareness among healthcare providers and patients about early disease detection is driving wider usage in preventive care. The integration of AI and automation in testing platforms is streamlining workflows and reducing errors, improving efficiency in laboratories. Expansion of point-of-care molecular testing is making diagnostics more accessible and timely, particularly in urgent care situations. Increasing investments in research and development by diagnostic companies is leading to innovative assays and platforms with broader test menus. Industry trends include a shift toward decentralized testing models, growth in companion diagnostics for targeted therapies, and rising collaborations between diagnostic developers and pharmaceutical companies. Opportunities lie in expanding test portfolios to address emerging pathogens, leveraging digital health integration for remote diagnostics, and advancing multiplex testing to detect multiple conditions in a single run. The market is positioned for sustained growth as precision medicine continues to shape healthcare, demanding fast, accurate, and scalable diagnostic solutions.
Molecular Diagnostics Market Report Highlights
By product, the reagents systems segment dominated the market with ~66% of the revenue share due to continuous demand for consumables in routine molecular diagnostic workflows.
Based on test location, the central laboratories segment held ~80% of the revenue share in 2024 due to their capability to process high testing volumes with advanced instrumentation and specialized expertise.
The North America molecular diagnostics market accounted for the largest revenue share of ~41% due to strong adoption of advanced molecular testing technologies, and supported by a well-established healthcare infrastructure.
The Asia Pacific market is expected to grow significantly during 2025-2034 due to increasing healthcare investments, rapid adoption of advanced diagnostic platforms, and the rising burden of chronic and infectious diseases.
A few global key players include Abbott; Agilent Technologies, Inc.; BD; BIOMERIEUX; Bio-Rad Laboratories, Inc.; Danaher; F. Hoffmann-La Roche, Ltd.; Grifols; Hologic Inc. (Gen Probe); Illumina, Inc.; QIAGEN; Siemens Healthineers AG; and Sysmex Corporation.
Polaris Market Research has segmented the molecular diagnostics market report on the basis of product, test location, technology, application, and region:
By Product Outlook (Revenue, USD Billion, 2020-2034)
Instruments
Reagents
Others
By Test Location Outlook (Revenue, USD Billion, 2020-2034)
Point of Care
Self-test or OTC
Central Laboratories
By Technology Outlook (Revenue, USD Billion, 2020-2034)
Polymerase Chain Reaction (PCR)
PCR, by Procedure
Nucleic Acid Extraction
Others
PCR, by Type
Multiplex PCR
Other PCR
PCR, by Product
Instruments
Reagents
Others
In Situ Hybridization (ISH)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Chips and Microarrays
Mass Spectrometry
Transcription Mediated Amplification (TMA)
Others
By Application Outlook (Revenue, USD Billion, 2020-2034)
Oncology
Pharmacogenomics
Infectious Disease
MRSA
Clostridium Difficile
Tuberculosis and Drug-Resistant TB
Meningitis
Gonorrhea
HIV
Hepatitis C
Hepatitis B
Others
Genetic Testing
Neurological Disease
Cardiovascular Disease
Microbiology
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Molecular Diagnostics Market Insights
- 4.1. Molecular Diagnostics Market - Market Snapshot
- 4.2. Molecular Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Infectious Diseases
- 4.2.1.2. Supportive Regulatory and Funding Initiatives
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of instruments and reagents limits adoption
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Molecular Diagnostics Market Power Rating Trends
- 4.6. Value Chain Analysis
5. Molecular Diagnostics Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
- 5.3. Instruments
- 5.3.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
- 5.4. Reagents
- 5.4.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
- 5.5. Others
- 5.5.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
6. Molecular Diagnostics Market, by Test Location
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 6.3. Point of care
- 6.3.1. Molecular Diagnostics Market, by Point of care, by Region, 2020-2034 (USD Billion)
- 6.4. Self-test or OTC
- 6.4.1. Molecular Diagnostics Market, by Self-test or OTC, by Region, 2020-2034 (USD Billion)
- 6.5. Central laboratories
- 6.5.1. Molecular Diagnostics Market, by Central laboratories, by Region, 2020-2034 (USD Billion)
7. Molecular Diagnostics Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 7.3. Polymerase chain reaction (PCR)
- 7.3.1. Molecular Diagnostics Market, by Polymerase chain reaction (PCR), by Region, 2020-2034 (USD Billion)
- 7.3.2. PCR, by Procedure
- 7.3.2.1. Molecular Diagnostics Market, by PCR, by Procedure, by Region, 2020-2034 (USD Billion)
- 7.3.2.2. Nucleic Acid Extraction
- 7.3.2.2.1. Molecular Diagnostics Market, by Nucleic Acid Extraction, by Region, 2020-2034 (USD Billion)
- 7.3.2.3. Others
- 7.3.2.3.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
- 7.3.3. PCR, by Type
- 7.3.3.1. Molecular Diagnostics Market, by PCR, by Type, by Region, 2020-2034 (USD Billion)
- 7.3.3.2. Multiplex PCR
- 7.3.3.2.1. Molecular Diagnostics Market, by Multiplex PCR, by Region, 2020-2034 (USD Billion)
- 7.3.3.3. Other PCR
- 7.3.3.3.1. Molecular Diagnostics Market, by Other PCR, by Region, 2020-2034 (USD Billion)
- 7.3.4. PCR, by Product
- 7.3.4.1. Molecular Diagnostics Market, by PCR, by Product, by Region, 2020-2034 (USD Billion)
- 7.3.4.2. Instruments
- 7.3.4.2.1. Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
- 7.3.4.3. Reagents
- 7.3.4.3.1. Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
- 7.3.4.4. Others
- 7.3.4.4.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
- 7.3.5. In Situ Hybridization (ISH)
- 7.3.5.1. Molecular Diagnostics Market, by In Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
- 7.4. Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.4.1. Molecular Diagnostics Market, by Isothermal Nucleic Acid Amplification Technology (INAAT), by Region, 2020-2034 (USD Billion)
- 7.5. Chips and Microarrays
- 7.5.1. Molecular Diagnostics Market, by Chips and Microarrays, by Region, 2020-2034 (USD Billion)
- 7.6. Mass Spectrometry
- 7.6.1. Molecular Diagnostics Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
- 7.7. Transcription Mediated Amplification (TMA)
- 7.7.1. Molecular Diagnostics Market, by Transcription Mediated Amplification (TMA), by Region, 2020-2034 (USD Billion)
- 7.8. Others
- 7.8.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
8. Molecular Diagnostics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 8.3. Oncology
- 8.3.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 8.4. Pharmacogenomics
- 8.4.1. Molecular Diagnostics Market, by Pharmacogenomics, by Region, 2020-2034 (USD Billion)
- 8.5. Infectious disease
- 8.5.1. Molecular Diagnostics Market, by Infectious disease, by Region, 2020-2034 (USD Billion)
- 8.5.2. Oncology
- 8.5.2.1. Molecular Diagnostics Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 8.5.3. MRSA
- 8.5.3.1. Molecular Diagnostics Market, by MRSA, by Region, 2020-2034 (USD Billion)
- 8.5.4. Clostridium difficile
- 8.5.4.1. Molecular Diagnostics Market, by Clostridium difficile, by Region, 2020-2034 (USD Billion)
- 8.5.5. Tuberculosis and drug-resistant TB
- 8.5.5.1. Molecular Diagnostics Market, by Tuberculosis and drug-resistant TB, by Region, 2020-2034 (USD Billion)
- 8.5.6. Meningitis
- 8.5.6.1. Molecular Diagnostics Market, by Meningitis, by Region, 2020-2034 (USD Billion)
- 8.5.7. Gonorrhea
- 8.5.7.1. Molecular Diagnostics Market, by Gonorrhea, by Region, 2020-2034 (USD Billion)
- 8.5.8. HIV
- 8.5.8.1. Molecular Diagnostics Market, by HIV, by Region, 2020-2034 (USD Billion)
- 8.5.9. Hepatitis C
- 8.5.9.1. Molecular Diagnostics Market, by Hepatitis C, by Region, 2020-2034 (USD Billion)
- 8.5.10. Hepatitis B
- 8.5.10.1. Molecular Diagnostics Market, by Hepatitis B, by Region, 2020-2034 (USD Billion)
- 8.5.11. Others
- 8.5.11.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
- 8.6. Genetic testing
- 8.6.1. Molecular Diagnostics Market, by Genetic testing, by Region, 2020-2034 (USD Billion)
- 8.7. Neurological disease
- 8.7.1. Molecular Diagnostics Market, by Neurological disease, by Region, 2020-2034 (USD Billion)
- 8.8. Cardiovascular disease
- 8.8.1. Molecular Diagnostics Market, by Cardiovascular disease, by Region, 2020-2034 (USD Billion)
- 8.9. Microbiology
- 8.9.1. Molecular Diagnostics Market, by Microbiology, by Region, 2020-2034 (USD Billion)
- 8.10. Others
- 8.10.1. Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)
9. Molecular Diagnostics Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Molecular Diagnostics Market - North America
- 9.3.1. North America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.3.2. North America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.3.3. North America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.3.5. Molecular Diagnostics Market - US
- 9.3.5.1. US: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.3.5.2. US: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.3.5.3. US: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.3.5.4. US: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.3.6. Molecular Diagnostics Market - Canada
- 9.3.6.1. Canada: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4. Molecular Diagnostics Market - Europe
- 9.4.1. Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.2. Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.3. Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.5. Molecular Diagnostics Market - UK
- 9.4.5.1. UK: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.6. Molecular Diagnostics Market - France
- 9.4.6.1. France: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.6.2. France: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.6.3. France: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.6.4. France: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.7. Molecular Diagnostics Market - Germany
- 9.4.7.1. Germany: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.8. Molecular Diagnostics Market - Italy
- 9.4.8.1. Italy: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.9. Molecular Diagnostics Market - Spain
- 9.4.9.1. Spain: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.10. Molecular Diagnostics Market - Netherlands
- 9.4.10.1. Netherlands: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.11. Molecular Diagnostics Market - Russia
- 9.4.11.1. Russia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.4.12. Molecular Diagnostics Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5. Molecular Diagnostics Market - Asia Pacific
- 9.5.1. Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.5. Molecular Diagnostics Market - China
- 9.5.5.1. China: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.5.2. China: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.5.3. China: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.5.4. China: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.6. Molecular Diagnostics Market - India
- 9.5.6.1. India: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.6.2. India: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.6.3. India: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.6.4. India: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.7. Molecular Diagnostics Market - Malaysia
- 9.5.7.1. Malaysia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.8. Molecular Diagnostics Market - Japan
- 9.5.8.1. Japan: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.9. Molecular Diagnostics Market - Indonesia
- 9.5.9.1. Indonesia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.10. Molecular Diagnostics Market - South Korea
- 9.5.10.1. South Korea: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.11. Molecular Diagnostics Market - Australia
- 9.5.11.1. Australia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.5.12. Molecular Diagnostics Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6. Molecular Diagnostics Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.5. Molecular Diagnostics Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.6. Molecular Diagnostics Market - UAE
- 9.6.6.1. UAE: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.7. Molecular Diagnostics Market - Israel
- 9.6.7.1. Israel: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.8. Molecular Diagnostics Market - South Africa
- 9.6.8.1. South Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.6.9. Molecular Diagnostics Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.7. Molecular Diagnostics Market - Latin America
- 9.7.1. Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.5. Molecular Diagnostics Market - Mexico
- 9.7.5.1. Mexico: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.6. Molecular Diagnostics Market - Brazil
- 9.7.6.1. Brazil: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.7. Molecular Diagnostics Market - Argentina
- 9.7.7.1. Argentina: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
- 9.7.8. Molecular Diagnostics Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Molecular Diagnostics Market, By Product, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Molecular Diagnostics Market, By Test Location, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Molecular Diagnostics Market, by Application, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Abbott
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Agilent Technologies, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. BD
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. BIOMERIEUX
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Bio-Rad Laboratories, Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Danaher
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. F. Hoffmann-La Roche, Ltd
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Grifols
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Hologic Inc. (Gen Probe)
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Illumina, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. QIAGEN
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Siemens Healthineers AG
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Sysmex Corporation
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
